Literature DB >> 10473034

The distribution of the maximum likelihood estimator in up-and-down experiments for quantal dose-response data.

M Vågerö1, R Sundberg.   

Abstract

Standard maximum likelihood logistic or probit regression has been used in biopharmaceutical practice for inference about tolerance threshold distributions in situations where subjects (patients) have been allocated doses according to an up-and-down design. For example, a steeper dose-response curve than expected was reported in one such study. This article demonstrates that the maximum likelihood estimator systematically and considerably exaggerates the regression parameter with moderately large sample sizes. Thus a probable explanation for finding a steeper curve than expected is the method used to analyze the experiment, that is, the bias in the maximum likelihood estimator. An additional consequence of this bias is that the mean/median/ED50 are estimated with a misleading precision. In particular, confidence intervals are much too narrow. As a conclusion, we warn against conventional logistic or probit regression in combination with up-and-down designs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473034     DOI: 10.1081/BIP-100101190

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial.

Authors:  Wenjun Meng; Fang Kang; Meirong Dong; Song Wang; Mingming Han; Xiang Huang; Sheng Wang; Juan Li; Chengwei Yang
Journal:  BMC Anesthesiol       Date:  2022-06-24       Impact factor: 2.376

2.  The EC(50) of remifentanil to minimize the cardiovascular changes during head holder pinning in neurosurgery.

Authors:  Wang Seok Do; Tae Kyun Kim; Hae Kyu Kim; Cheul Hong Kim
Journal:  Korean J Anesthesiol       Date:  2012-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.